Nothing Special   »   [go: up one dir, main page]

DK3325080T3 - Fremgangsmåder til bedre indgivelse af aktive midler til tumorer - Google Patents

Fremgangsmåder til bedre indgivelse af aktive midler til tumorer Download PDF

Info

Publication number
DK3325080T3
DK3325080T3 DK16831139.7T DK16831139T DK3325080T3 DK 3325080 T3 DK3325080 T3 DK 3325080T3 DK 16831139 T DK16831139 T DK 16831139T DK 3325080 T3 DK3325080 T3 DK 3325080T3
Authority
DK
Denmark
Prior art keywords
tumors
procedures
active agents
better administration
administration
Prior art date
Application number
DK16831139.7T
Other languages
English (en)
Inventor
Russell Frederick Ross
Original Assignee
Sorrento Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sorrento Therapeutics Inc filed Critical Sorrento Therapeutics Inc
Application granted granted Critical
Publication of DK3325080T3 publication Critical patent/DK3325080T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
DK16831139.7T 2015-07-24 2016-07-22 Fremgangsmåder til bedre indgivelse af aktive midler til tumorer DK3325080T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562196570P 2015-07-24 2015-07-24
US201562196578P 2015-07-24 2015-07-24
PCT/US2016/043623 WO2017019526A2 (en) 2015-07-24 2016-07-22 Methods for better delivery of active agents to tumors

Publications (1)

Publication Number Publication Date
DK3325080T3 true DK3325080T3 (da) 2021-10-04

Family

ID=57885141

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16831139.7T DK3325080T3 (da) 2015-07-24 2016-07-22 Fremgangsmåder til bedre indgivelse af aktive midler til tumorer

Country Status (15)

Country Link
US (3) US10806913B2 (da)
EP (2) EP3325080B1 (da)
JP (1) JP7082041B2 (da)
KR (1) KR20180035209A (da)
CN (2) CN118902979A (da)
AU (3) AU2016297823B2 (da)
BR (1) BR112018001292A2 (da)
CA (1) CA2991455C (da)
DK (1) DK3325080T3 (da)
ES (1) ES2891523T3 (da)
HU (1) HUE056410T2 (da)
MX (2) MX2018000166A (da)
PL (1) PL3325080T3 (da)
RU (1) RU2719943C2 (da)
WO (1) WO2017019526A2 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107949418B (zh) * 2015-07-24 2024-07-02 索伦托治疗有限公司 用于活性剂的淋巴递送的方法
HUE056410T2 (hu) * 2015-07-24 2022-02-28 Sorrento Therapeutics Inc Eljárások a hatóanyagok jobb bejuttatására a tumorokba
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
BR112019023985A2 (pt) 2017-05-17 2020-06-09 Massachusetts Inst Technology sistema de autocorreção e componentes e métodos relacionados
WO2019012382A1 (en) 2017-07-10 2019-01-17 Basf Se MIXTURES COMPRISING A UREASE INHIBITOR (UI) AND A NITRIFICATION INHIBITOR SUCH AS 2- (3,4-DIMETHYL-1H-PYRAZOL-1-YL) SUCCINIC ACID (DMPSA) OR 3,4-DIMETHYL PYRAZOLIUM GLYCOLATE (DMPG)
WO2019222570A1 (en) 2018-05-17 2019-11-21 Massachusetts Institute Of Technology Systems for electrical stimulation
JP2021525576A (ja) * 2018-05-31 2021-09-27 ソレント・セラピューティクス・インコーポレイテッドＳｏｒｒｅｎｔｏ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． リンパ系を標的化した薬物送達方法
US20210308440A1 (en) * 2018-09-24 2021-10-07 L'oreal Device comprising microneedles for skin-coloring
JP2023505231A (ja) 2019-12-05 2023-02-08 ソレント・セラピューティクス・インコーポレイテッド リンパ管送達デバイスによる抗ｐｄ－１または抗ｐｄ－ｌ１治療剤の投与による癌の処置方法
EP4281167A1 (en) 2021-01-22 2023-11-29 Sorrento Therapeutics, Inc. Device for microliter-scale lymphatic delivery of coronavirus vaccines
WO2022192594A2 (en) 2021-03-11 2022-09-15 Sorrento Therapeutics, Inc. Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease
WO2022261262A1 (en) 2021-06-09 2022-12-15 Sorrento Therapeutics, Inc. Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic microneedle delivery device
WO2023023074A1 (en) 2021-08-18 2023-02-23 Sorrento Therapeutics, Inc. Therapeutic agents targeting the lymphatic system

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
AU785199B2 (en) 2000-06-01 2006-11-02 Watson Pharmaceuticals, Inc. Transdermal delivery of lasofoxifene
MXPA04002283A (es) * 2001-09-12 2004-06-29 Becton Dickinson Co Dispositivo de pluma a base de microaguja para el suministro de farmaco y metodo para utilizar el mismo.
EP1635876A4 (en) * 2003-06-13 2009-05-06 Becton Dickinson Co IMPROVED INTRADERMAL ADMINISTRATION OF BIOACTIVE AGENTS
WO2005023328A2 (en) 2003-08-26 2005-03-17 Becton Dickinson And Company Methods for intradermal delivery of therapeutics agents
US7780981B2 (en) * 2004-09-13 2010-08-24 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
US20070088414A1 (en) 2005-05-25 2007-04-19 Campbell Robert L Particulate formulations for intradermal delivery of biologically active agents
US20080213461A1 (en) * 2005-06-17 2008-09-04 Georgia Tech Research Corporation Coated Microstructures and Methods of Manufacture Thereof
US8197435B2 (en) * 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
EP2100850A1 (en) * 2008-03-11 2009-09-16 Stichting Voor De Technische Wetenschappen Microneedle array and a method for manufacturing microneedles
US8715736B2 (en) * 2009-04-30 2014-05-06 Florida Agricultural And Mechanical University Nanoparticle formulations for skin delivery
CN101829394B (zh) * 2010-04-27 2012-08-22 上海交通大学 台阶微针阵列的制备方法
AU2011311255B2 (en) 2010-04-28 2015-10-08 Sorrento Therapeutics, Inc. Method for increasing permeability of an epithelial barrier
RU2585159C2 (ru) 2010-04-28 2016-05-27 Кимберли-Кларк Ворлдвайд, Инк. Устройство доставки лекарственного средства, применяемого при ревматоидном артрите
KR101794377B1 (ko) 2010-04-28 2017-11-06 킴벌리-클라크 월드와이드, 인크. 나노구조체를 포함하는 복합형 마이크로니들 어레이
CA2797205C (en) 2010-04-28 2019-04-16 Kimberly-Clark Worldwide, Inc. Medical devices for delivery of sirna
US20120187814A1 (en) 2011-01-25 2012-07-26 Fryling Nicholas A Furniture System and a Frame Assembly for a Furniture System
US20120245445A1 (en) * 2011-03-21 2012-09-27 Michael Darryl Black Glucose Monitoring System
PL2768942T3 (pl) * 2011-10-17 2020-05-18 Massachusetts Institute Of Technology Dostarczanie dokomórkowe
US9550053B2 (en) * 2011-10-27 2017-01-24 Kimberly-Clark Worldwide, Inc. Transdermal delivery of high viscosity bioactive agents
KR101575039B1 (ko) 2012-07-19 2015-12-07 (주)아모레퍼시픽 노즐 장치 및 이를 포함하는 최소 침습형 주입 장치
WO2014041531A1 (en) * 2012-09-13 2014-03-20 Amir Avraham Delivery devices and methods for skin augmentation
SMT202000452T1 (it) * 2012-09-21 2020-09-10 Intensity Therapeutics Inc Metodo di trattamento del cancro
CN103157178B (zh) * 2013-02-05 2014-12-31 北京化工大学 精确控制微针插入长度的印章式工具
KR102571835B1 (ko) 2013-02-28 2023-08-30 소렌토 쎄라퓨틱스, 인코포레이티드 경피 약물 전달 장치
EP2961469A4 (en) 2013-02-28 2016-10-26 Kimberly Clark Co DEVICE FOR DELIVERY OF MEDICAMENT
JP2016517762A (ja) 2013-05-23 2016-06-20 キンバリー クラーク ワールドワイド インコーポレイテッド 開放チャネル断面形状が改善されたマイクロニードル
US10376674B2 (en) * 2014-09-15 2019-08-13 Ethicon, Inc. System and method for targeted delivery of therapeutic agents to tissue
CN107949418B (zh) * 2015-07-24 2024-07-02 索伦托治疗有限公司 用于活性剂的淋巴递送的方法
HUE056410T2 (hu) * 2015-07-24 2022-02-28 Sorrento Therapeutics Inc Eljárások a hatóanyagok jobb bejuttatására a tumorokba

Also Published As

Publication number Publication date
CN107921248A (zh) 2018-04-17
BR112018001292A2 (pt) 2018-09-11
CN118902979A (zh) 2024-11-08
US20180193624A1 (en) 2018-07-12
KR20180035209A (ko) 2018-04-05
EP3325080B1 (en) 2021-09-01
AU2021200146A1 (en) 2021-03-18
EP3325080A2 (en) 2018-05-30
US20210052871A1 (en) 2021-02-25
CA2991455A1 (en) 2017-02-02
HUE056410T2 (hu) 2022-02-28
RU2018104102A (ru) 2019-08-27
ES2891523T3 (es) 2022-01-28
AU2022275397A1 (en) 2023-01-05
MX2022014277A (es) 2022-12-07
US10806913B2 (en) 2020-10-20
JP7082041B2 (ja) 2022-06-07
EP3925599A1 (en) 2021-12-22
AU2021200146B2 (en) 2022-08-25
PL3325080T3 (pl) 2022-01-24
AU2016297823A1 (en) 2018-02-15
CA2991455C (en) 2023-10-10
AU2016297823B2 (en) 2020-10-22
JP2018521755A (ja) 2018-08-09
RU2018104102A3 (da) 2019-11-06
MX2018000166A (es) 2018-03-26
EP3325080A4 (en) 2019-04-17
RU2719943C2 (ru) 2020-04-23
US20240238570A1 (en) 2024-07-18
WO2017019526A2 (en) 2017-02-02

Similar Documents

Publication Publication Date Title
IL281863A (en) Pharmaceutical compositions comprising meloxicam
IL282304A (en) Topical pharmaceutical compositions
DK3325080T3 (da) Fremgangsmåder til bedre indgivelse af aktive midler til tumorer
HK1256383A1 (zh) 治療劑
DK3797742T3 (da) Indretning til suprakoroidal indgivelse af terapeutisk middel
DK3356313T3 (da) 2-perfluorhexyloktan til oftalmisk indgivelse
DK3350157T3 (da) Forbindelser og sammensætninger til intracellulær afgivelse af terapeutiske midler
DK3439635T3 (da) Formuleringer til behandling af fast tumor
DK3139986T3 (da) System til administration af terapeutisk gas
DK3236943T3 (da) Sammensætninger til ileo-jejunal lægemiddeladministration
DK3302565T3 (da) Faste doseringsformer af palbociclib
DK3377516T3 (da) Sammensætning til behandling af cancer
EP3397250C0 (en) LONG-TERM TRANSDERMAL DELIVERY SYSTEMS
DK3253382T3 (da) Farmaceutiske sammensætninger til kombinationsterapi
DK3554240T3 (da) Kombinationer af aktive forbindelser
DK3116491T3 (da) Farmaceutiske sammensætninger af terapeutisk aktive forbindelser
DK3317400T3 (da) Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter
DK3310904T3 (da) System til cellulær indgivelse af målrettet aktivstof
DK3378482T3 (da) Formulering til administration af antitumorlægemiddel
KR102494289B9 (ko) 활성 혼합물
DK3204398T3 (da) Fremgangsmåder til fraseparering af gemcitabin-phosphat diastereoisomerer
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
DK3233813T3 (da) Fremgangsmåder til fremstilling af oxathiazin-lignende forbindelser
DK3325483T3 (da) Fremgangsmåder til fremstilling af cytotoksiske benzodiazepinderivater
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin